Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Gleave

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Molecular Urology|November 3, 2001
Acquisition of resistance to Fas-mediated apoptosis by overexpression of clusterin in human renal-cell carcinoma cellsH Miyake, S Hara, T Zellweger, et al.
World Journal of Urology|December 2, 2015
Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomyH Abdi, F Pourmalek, M E Gleave, et al.
The Canadian Journal of Urology|January 15, 2002
Inflammatory pseudotumor of the urinary bladder: a report of five cases and review of the literatureK S Poon, O Moreira, E C Jones, et al.
Urology|May 1, 1995
Intermittent androgen suppression in the treatment of prostate cancer: a preliminary reportS L Goldenberg, N Bruchovsky, M E Gleave, et al.
The Journal of Urology|April 1, 1992
Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasisM E Gleave, J T Hsieh, A C von Eschenbach, et al.
Cancer|August 1, 1996
Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elementsF Rabbani, M E Gleave, C M Coppin, et al.
British Journal of Cancer|October 6, 2005
Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical studyL Lessard, L R Bégin, M E Gleave, et al.
British Journal of Cancer|October 22, 2009
Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cellsT Terakawa, H Miyake, J Furukawa, et al.
Neoplasia (New York, N.Y.)|September 26, 2001
Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterinT Zellweger, H Miyake, L V July, et al.
The Journal of Urology|January 1, 1996
Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancerM E Gleave, S L Goldenberg, E C Jones, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Molecular Urology|November 3, 2001
Acquisition of resistance to Fas-mediated apoptosis by overexpression of clusterin in human renal-cell carcinoma cellsH Miyake, S Hara, T Zellweger, et al.
World Journal of Urology|December 2, 2015
Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomyH Abdi, F Pourmalek, M E Gleave, et al.
The Canadian Journal of Urology|January 15, 2002
Inflammatory pseudotumor of the urinary bladder: a report of five cases and review of the literatureK S Poon, O Moreira, E C Jones, et al.
Urology|May 1, 1995
Intermittent androgen suppression in the treatment of prostate cancer: a preliminary reportS L Goldenberg, N Bruchovsky, M E Gleave, et al.
The Journal of Urology|April 1, 1992
Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasisM E Gleave, J T Hsieh, A C von Eschenbach, et al.
Cancer|August 1, 1996
Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elementsF Rabbani, M E Gleave, C M Coppin, et al.
British Journal of Cancer|October 6, 2005
Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical studyL Lessard, L R Bégin, M E Gleave, et al.
British Journal of Cancer|October 22, 2009
Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cellsT Terakawa, H Miyake, J Furukawa, et al.
Neoplasia (New York, N.Y.)|September 26, 2001
Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterinT Zellweger, H Miyake, L V July, et al.
The Journal of Urology|January 1, 1996
Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancerM E Gleave, S L Goldenberg, E C Jones, et al.
Pageof 9